These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 11196548

  • 21. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus.
    Jørgensen MH, Rekvig OP, Jacobsen RS, Jacobsen S, Fenton KA.
    Immunol Lett; 2011 Aug 30; 138(2):179-86. PubMed ID: 21530588
    [Abstract] [Full Text] [Related]

  • 22. The binding of lupus-derived autoantibodies to the C-terminal peptide (83-119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes.
    Dieker JW, Van Bavel CC, Riemekasten G, Berden JH, van der Vlag J.
    Ann Rheum Dis; 2006 Nov 30; 65(11):1525-8. PubMed ID: 16540553
    [Abstract] [Full Text] [Related]

  • 23. Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies.
    Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach JF.
    Eur J Immunol; 1996 Feb 30; 26(2):472-86. PubMed ID: 8617320
    [Abstract] [Full Text] [Related]

  • 24. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC, Harmon ME, Burlingame R, Du Clos TW.
    J Rheumatol; 2005 Mar 30; 32(3):454-61. PubMed ID: 15742436
    [Abstract] [Full Text] [Related]

  • 25. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul 30; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS, Chowdhary AR, Khalil N, Ali R.
    Clin Immunol; 2007 Jul 30; 124(1):83-9. PubMed ID: 17540620
    [Abstract] [Full Text] [Related]

  • 27. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun 30; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 28. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I, Landolsi H, Mankai A, Fabien N, Jeddi M.
    Pathol Biol (Paris); 2006 Apr 30; 54(3):148-54. PubMed ID: 16169158
    [Abstract] [Full Text] [Related]

  • 29. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies.
    Dieker JW, Sun YJ, Jacobs CW, Putterman C, Monestier M, Muller S, van der Vlag J, Berden JH.
    J Immunol Methods; 2005 Jan 30; 296(1-2):83-93. PubMed ID: 15680153
    [Abstract] [Full Text] [Related]

  • 30. Antinucleosome antibodies and systemic lupus erythematosus.
    Düzgün N, Sahin M, Genç Y, Tutkak H.
    Ann N Y Acad Sci; 2007 Aug 30; 1109():421-8. PubMed ID: 17785331
    [Abstract] [Full Text] [Related]

  • 31. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
    Amoura Z, Piette JC, Chabre H, Cacoub P, Papo T, Wechsler B, Bach JF, Koutouzov S.
    Arthritis Rheum; 1997 Dec 30; 40(12):2217-25. PubMed ID: 9416860
    [Abstract] [Full Text] [Related]

  • 32. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients.
    Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari PF.
    J Autoimmun; 2004 May 30; 22(3):235-40. PubMed ID: 15041044
    [Abstract] [Full Text] [Related]

  • 33. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan 30; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 34. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K.
    J Immunol Methods; 2010 Jan 31; 352(1-2):147-52. PubMed ID: 19836394
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus.
    Dieker JW, Fransen JH, van Bavel CC, Briand JP, Jacobs CW, Muller S, Berden JH, van der Vlag J.
    Arthritis Rheum; 2007 Jun 31; 56(6):1921-33. PubMed ID: 17530637
    [Abstract] [Full Text] [Related]

  • 37. Monoclonal anti-histone autoantibodies derived from murine models of lupus.
    Kotzin BL, Lafferty JA, Portanova JP, Rubin RL, Tan EM.
    J Immunol; 1984 Nov 31; 133(5):2554-9. PubMed ID: 6332855
    [Abstract] [Full Text] [Related]

  • 38. Clinical significance of antibodies to histones in systemic lupus erythematosus.
    Kohda S, Kanayama Y, Okamura M, Amatsu K, Negoro N, Takeda T, Inoue T.
    J Rheumatol; 1989 Jan 31; 16(1):24-8. PubMed ID: 2785597
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 31; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.